ZEISS Unveils Next Generation Retina Care Solutions at EURETINA 2025 Conference

ZEISS Showcases Advanced Retina Solutions at EURETINA 2025

At the upcoming EURETINA 2025 conference from September 4 to 7 in Paris, ZEISS Medical Technology will unveil its most comprehensive portfolio focused on retinal care. By merging diagnostic, surgical, and digital technologies, ZEISS aims to provide healthcare professionals with enhanced tools to improve the standards of retinal care.

Innovations in Pathology Detection

One significant highlight will be the CIRRUS® PathFinder™ AI decision support tool, which has recently received CE mark approval. This tool revolutionizes optical coherence tomography (OCT) data review by utilizing artificial intelligence to assist healthcare professionals in identifying pathologies more efficiently. Furthermore, the CLARUS® 700 will also be showcased with simultaneous fluorescence and indocyanine green angiography capabilities, allowing eye specialists to capture detailed imaging from early to late phases of assessment.

Empowering Retina Research

Alongside diagnostic advancements, the ZEISS Research Data Platform (RDP) showcases how retina specialists can leverage AI-driven insights to transform clinical hypotheses into tracked outcomes. This cloud-based solution targets researchers intending to gather real-world clinical evidence and enhance their experimental methodologies. The combination of AI algorithm training and biomarker generation promises a significant leap in ophthalmic research efficacy.

Transformative Surgical Solutions

At the conference, ZEISS will also introduce the TDC VELOCE™, a high-speed cutter designed for the DORC EVA NEXUS™ platform, which is vital for posterior vitreoretinal surgery. Coupled with innovative fluidics technology, it assures constant intraoperative stability and enhanced surgical precision, bringing new possibilities for ophthalmic procedures. This cutter’s ergonomic design, advancing cut speeds, and improved aspiration flow attest to ZEISS's commitment to supporting efficient surgical maneuvers.

Enhanced Visualization Capabilities

Another major development is the integration of updated ZEISS CALLISTO eye® software. Attendees will see advancements in visualization technology with the ARTEVO® 850 and ARTEVO® 750. The upgraded software provides high-resolution imaging with customizable parameters, significantly improving the user experience for surgeons performing vitrectomy and cataract surgeries. With features such as automatic exposure control and enhanced 3D visualization, surgeons can expect to make more informed decisions during intricate operations.

A Symposium of Knowledge

Throughout the EURETINA event, ZEISS will host educational sessions led by prominent thought leaders. Dr. Ricardo Leitao Guerra and Dr. Harvey Uy will discuss the practical applications of the ZEISS Retina Workflow, sharing valuable insights from their clinical experiences.

Conclusion

In conclusion, ZEISS's presentation at EURETINA 2025 marks a significant step forward in retinal care technology. By offering a seamless integration of diagnostics, surgical tools, and artificial intelligence, ZEISS empowers healthcare professionals to elevate patient care standards. Visitors can find ZEISS at booth #2.B20 to explore these transformative technologies in-depth. The future of retinal surgery and diagnosis is brighter than ever with ZEISS leading the way.